Investor caution, driven by lengthy RD cycles and monetisation processes, binary outcomes, and a lack of technical expertise, is undergoing transformation, said Bain. Twelve of the top 20 global Pharma firms have set up Global Capability Centres in India
from Moneycontrol Business News https://ift.tt/AcynXIL
from Moneycontrol Business News https://ift.tt/AcynXIL